Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 635748, 8 pages
http://dx.doi.org/10.1155/2015/635748
Research Article

MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion

1Department of Chest Diseases, Medical Faculty, Eskisehir Osmangazi University, 26480 Eskisehir, Turkey
2Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
3Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
4Division of Oncology, National Jewish Health, Denver, CO 80206, USA
5Department of Public Health, Medical Faculty, Eskisehir Osmangazi University, 26480 Eskisehir, Turkey
6Department of Pathology, Medical Faculty, Eskisehir Osmangazi University, 26480 Eskisehir, Turkey
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
8Division of Pulmonary & Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA

Received 31 August 2014; Accepted 27 October 2014

Academic Editor: Seiichi Saito

Copyright © 2015 Guntulu Ak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ray and H. L. Kindler, “Malignant pleural mesothelioma: an update on biomarkers and treatment,” Chest, vol. 136, no. 3, pp. 888–896, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. W. S. Robinson and A. W. Musk, “Benign asbestos pleural effusion: diagnosis and course,” Thorax, vol. 36, no. 12, pp. 896–900, 1981. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Calin, C. Sevignani, C. D. Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Wang, C. Qiu, H. Zhang, J. Wang, Q. Cui, and Y. Yin, “Human MicroRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets,” PLoS ONE, vol. 5, no. 9, Article ID e13067, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Volinia, G. A. Calin, C. G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Google Scholar
  6. N. Yanaihara, N. Caplen, E. Bowman et al., “Unique microRNA molecular profiles in lung cancer diagnosis and prognosis,” Cancer Cell, vol. 9, no. 3, pp. 189–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Yu, H. Y. Chen, G. C. Chang et al., “MicroRNA signature predicts survival and relapse in lung cancer,” Cancer Cell, vol. 13, pp. 48–57, 2008. View at Publisher · View at Google Scholar
  8. E. Duncavage, B. Goodgame, A. Sezhiyan, R. Govindan, and J. Pfeifer, “Use of MicroRNA expression levels to predict outcomes in resected stage i non-small cell lung cancer,” Journal of Thoracic Oncology, vol. 5, no. 11, pp. 1755–1763, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. He, J. F. Zhang, C. Yi et al., “miRNA-mediated functional changes through co-regulating function related genes,” PLoS ONE, vol. 5, no. 10, Article ID e13558, 2010. View at Publisher · View at Google Scholar
  10. H. I. Pass, C. Goparaju, S. Ivanov et al., “hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma,” Cancer Research, vol. 70, no. 5, pp. 1916–1924, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Guled, L. Lahti, P. M. Lindholm et al., “CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—a mirna microarray analysis,” Genes Chromosomes and Cancer, vol. 48, no. 7, pp. 615–623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Busacca, S. Germano, L. D. Cecco et al., “MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 3, pp. 312–319, 2010. View at Publisher · View at Google Scholar
  13. H. Benjamin, D. Lebanony, S. Rosenwald et al., “A diagnostic assay based on MicroRNA expression accurately identifies malignant pleural mesothelioma,” Journal of Molecular Diagnostics, vol. 12, no. 6, pp. 771–779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. V. Gee, D. C. Koestler, B. C. Christensen et al., “Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma,” International Journal of Cancer, vol. 127, no. 12, pp. 2859–2869, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Balatti, S. Maniero, M. Ferracin et al., “MicroRNAs dysregulation in human malignant pleural mesothelioma,” Journal of Thoracic Oncology, vol. 6, no. 5, pp. 844–851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. V. Ivanov, C. M. V. Goparaju, P. Lopez et al., “Pro-tumorigenic effects of miR-31 loss in mesothelioma,” The Journal of Biological Chemistry, vol. 285, no. 30, pp. 22809–22817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Santarelli, E. Strafella, S. Staffolani et al., “Association of miR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma,” PLoS ONE, vol. 6, no. 4, Article ID e18232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. G. Weber, G. Johnen, O. Bryk, K.-H. Jöckel, and T. Brüning, “Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma—a pilot study,” PLoS ONE, vol. 7, no. 1, Article ID e30221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. B. Kirschner, Y. Y. Cheng, B. Badrian et al., “Increased circulating miR-625-3p. A potential biomarker for patients with malignant pleural mesothelioma,” Journal of Thoracic Oncology, vol. 7, pp. 1184–1191, 2012. View at Publisher · View at Google Scholar
  20. H. I. Pass, Z. Liu, A. Wali et al., “Gene expression profiles predict survival and progression of pleural mesothelioma,” Clinical Cancer Research, vol. 10, no. 3, pp. 849–859, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Zanazzi, R. Hersmus, I. M. Veltman et al., “Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines,” Genes Chromosomes and Cancer, vol. 46, no. 10, pp. 895–908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Crispi, R. A. Calogero, M. Santini et al., “Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target,” PLoS ONE, vol. 4, no. 9, Article ID e7016, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. O. D. Røe, E. Anderssen, E. Helge et al., “Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype,” PLoS ONE, vol. 4, no. 8, Article ID e6554, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B. C. Christensen, E. A. Houseman, J. J. Godleski et al., “Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome,” Cancer Research, vol. 69, no. 1, pp. 227–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Bueno, A. de Rienzo, L. Dong et al., “Second generation sequencing of the mesothelioma tumor genome,” PLoS ONE, vol. 5, Article ID e10612, 2010. View at Publisher · View at Google Scholar
  26. J. D. Storey and R. Tibshirani, “Statistical significance for genomewide studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9440–9445, 2003. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  27. T. R. Golub, D. K. Slonim, P. Tamayo et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,” Science, vol. 286, no. 5439, pp. 531–537, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Bauer, J. Gagneur, and P. N. Robinson, “Going Bayesian: model-based gene set analysis of genome-scale data,” Nucleic Acids Research, vol. 38, no. 11, Article ID gkq045, pp. 3523–3532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H. E. Davies, J. E. Nicholson, N. M. Rahman, E. M. Wilkinson, R. J. O. Davies, and Y. C. G. Lee, “Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies,” European Journal of Cardio-Thoracic Surgery, vol. 38, no. 4, pp. 472–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Villanova, A. Procopio, and M. R. Rippo, “Malignant mesothelioma resistance to apoptosis: recent discoveries and their implication for effective therapeutic strategies,” Current Medicinal Chemistry, vol. 15, no. 7, pp. 631–641, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. P. A. Zucali, G. L. Ceresoli, F. de Vincenzo et al., “Advances in the biology of malignant pleural mesothelioma,” Cancer Treatment Reviews, vol. 37, no. 7, pp. 543–558, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Levallet, M. Vaisse-Lesteven, N. Le Stang et al., “Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH group,” Journal of Thoracic Oncology, vol. 7, no. 3, pp. 599–606, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Cacciotti, R. Libener, P. Betta et al., “SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 21, pp. 12032–12037, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Foddis, A. De Rienzo, D. Broccoli et al., “SV40 infection induces telomerase activity in human mesothelial cells,” Oncogene, vol. 21, no. 9, pp. 1434–1442, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Bocchetta, L. Miele, H. I. Pass, and M. Carbone, “Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells,” Oncogene, vol. 22, no. 1, pp. 81–89, 2003. View at Publisher · View at Google Scholar · View at Scopus